276 related articles for article (PubMed ID: 30873562)
1. Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardiac stress.
Laudette M; Coluccia A; Sainte-Marie Y; Solari A; Fazal L; Sicard P; Silvestri R; Mialet-Perez J; Pons S; Ghaleh B; Blondeau JP; Lezoualc'h F
Cardiovasc Res; 2019 Oct; 115(12):1766-1777. PubMed ID: 30873562
[TBL] [Abstract][Full Text] [Related]
2. Exchange protein directly activated by cAMP 1 promotes autophagy during cardiomyocyte hypertrophy.
Laurent AC; Bisserier M; Lucas A; Tortosa F; Roumieux M; De Régibus A; Swiader A; Sainte-Marie Y; Heymes C; Vindis C; Lezoualc'h F
Cardiovasc Res; 2015 Jan; 105(1):55-64. PubMed ID: 25411381
[TBL] [Abstract][Full Text] [Related]
3. Novel Epac fluorescent ligand reveals distinct Epac1 vs. Epac2 distribution and function in cardiomyocytes.
Pereira L; Rehmann H; Lao DH; Erickson JR; Bossuyt J; Chen J; Bers DM
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):3991-6. PubMed ID: 25829540
[TBL] [Abstract][Full Text] [Related]
4. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
[TBL] [Abstract][Full Text] [Related]
7. Exchange protein activated by cyclic-adenosine monophosphate (Epac) regulates atrial fibroblast function and controls cardiac remodelling.
Surinkaew S; Aflaki M; Takawale A; Chen Y; Qi XY; Gillis MA; Shi YF; Tardif JC; Chattipakorn N; Nattel S
Cardiovasc Res; 2019 Jan; 115(1):94-106. PubMed ID: 30016400
[TBL] [Abstract][Full Text] [Related]
8. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
[TBL] [Abstract][Full Text] [Related]
9. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death.
Tang Y; Wang Y; Park KM; Hu Q; Teoh JP; Broskova Z; Ranganathan P; Jayakumar C; Li J; Su H; Tang Y; Ramesh G; Kim IM
Cardiovasc Res; 2015 Jun; 106(3):387-97. PubMed ID: 25824147
[TBL] [Abstract][Full Text] [Related]
12. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen Receptor β Activation Protects Against Myocardial Infarction via Notch1 Signalling.
Du M; Shan J; Feng A; Schmull S; Gu J; Xue S
Cardiovasc Drugs Ther; 2020 Apr; 34(2):165-178. PubMed ID: 32157565
[TBL] [Abstract][Full Text] [Related]
14. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
Kwak HJ; Park KM; Choi HE; Chung KS; Lim HJ; Park HY
Cell Signal; 2008 May; 20(5):803-14. PubMed ID: 18276108
[TBL] [Abstract][Full Text] [Related]
15. Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
Métrich M; Lucas A; Gastineau M; Samuel JL; Heymes C; Morel E; Lezoualc'h F
Circ Res; 2008 Apr; 102(8):959-65. PubMed ID: 18323524
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
[TBL] [Abstract][Full Text] [Related]
18. G protein-coupled receptor kinase 5 (GRK5) contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure.
de Lucia C; Grisanti LA; Borghetti G; Piedepalumbo M; Ibetti J; Lucchese AM; Barr EW; Roy R; Okyere AD; Murphy HC; Gao E; Rengo G; Houser SR; Tilley DG; Koch WJ
Cardiovasc Res; 2022 Jan; 118(1):169-183. PubMed ID: 33560342
[TBL] [Abstract][Full Text] [Related]
19. Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway.
Métrich M; Laurent AC; Breckler M; Duquesnes N; Hmitou I; Courillau D; Blondeau JP; Crozatier B; Lezoualc'h F; Morel E
Cell Signal; 2010 Oct; 22(10):1459-68. PubMed ID: 20576488
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy.
Duerr GD; Heinemann JC; Suchan G; Kolobara E; Wenzel D; Geisen C; Matthey M; Passe-Tietjen K; Mahmud W; Ghanem A; Tiemann K; Alferink J; Burgdorf S; Buchalla R; Zimmer A; Lutz B; Welz A; Fleischmann BK; Dewald O
Basic Res Cardiol; 2014 Jul; 109(4):425. PubMed ID: 24980781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
